DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC)


$5.2850
-0.0900 ( -1.22% ) 40.8K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$5.2850

Previous close


$5.3750

Volume


40.8K

Market cap


$228.13M

Day range


$5.2300 - $5.5090

52 week range


$2.1400 - $6.4100

SEC Filings


Form Type Description Pages Date
8-k 8K-related 23 Nov 13, 2024
10-q Quarterly Reports 67 Nov 13, 2024
8-k 8K-related 16 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 49 Jun 26, 2024
8-k 8K-related 18 Jun 26, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024

Latest News